Welcome to our dedicated page for Rising Dragon Acquisition SEC filings (Ticker: RDAC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Rising Dragon Acquisition's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Rising Dragon Acquisition's regulatory disclosures and financial reporting.
Rising Dragon Acquisition Corp. (RDAC) postponed its Extraordinary General Meeting from October 20, 2025 to November 20, 2025 at 10:00 a.m. ET. The company said the delay is to provide shareholders additional time to review the definitive proxy statement and vote.
The location and proposals remain unchanged, with the meeting held at Loeb & Loeb LLP in New York and virtually. The redemption request deadline tied to the proposed business combination moved from October 16, 2025 to November 18, 2025, and previously submitted redemptions may be revoked before the new deadline. A press release was furnished as Exhibit 99.1.
Rising Dragon Acquisition Corp. is soliciting shareholder approval for a business combination that includes HZJL (a target business). The proxy shows Rising Dragon obtained a fairness opinion from CHFT Advisory and Appraisal, Ltd. and that approximately $58.33 million is held in the SPAC trust account available for the transaction.
The filing discloses a net tangible book value deficit of $57,747,823 and that 5,750,000 public shares are subject to possible redemption. Pro forma analyses present multiple redemption scenarios that would materially reduce post-closing cash (examples shown reduce remaining cash from $56.9M down to as low as $474,678 depending on redemptions and fees). The proxy also shows dilution metrics to HZJL merger recipients ranging from $3.10 to $10.55 per share and required pro forma company valuations (approximately $448.5M to $393.1M) for non-redeeming shareholders to equal the original SPAC IPO price.